133099-79-3 Usage
Uses
Used in Pharmaceutical Development:
H-D-Ser-Obzl Hydrochloride salt is used as a building block for the synthesis of pharmaceutical compounds. Its unique structure, including the serine amino acid, hydrochloride salt, and obzl group, allows for the creation of novel drug candidates with potential therapeutic applications.
Used in Research:
H-D-Ser-Obzl Hydrochloride salt is used as a research tool for studying the properties and functions of serine-containing compounds. Its solubility and chemical versatility make it an ideal candidate for investigating the role of serine in biological processes and its potential interactions with other molecules.
Used in Drug Delivery Systems:
H-D-Ser-Obzl Hydrochloride salt is used as a component in drug delivery systems to improve the solubility, stability, and bioavailability of therapeutic agents. The hydrochloride salt enhances the compound's water solubility, while the obzl group may provide specific chemical properties that facilitate drug delivery and release.
Used in Chemical Synthesis:
H-D-Ser-Obzl Hydrochloride salt is used as a reactant or intermediate in the synthesis of various chemical compounds. Its unique structure allows for the formation of new molecules with potential applications in various industries, including pharmaceuticals, materials science, and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 133099-79-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,0,9 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 133099-79:
(8*1)+(7*3)+(6*3)+(5*0)+(4*9)+(3*9)+(2*7)+(1*9)=133
133 % 10 = 3
So 133099-79-3 is a valid CAS Registry Number.
133099-79-3Relevant articles and documents
Stereoselective synthesis of natural and non-natural thomsen-nouveau antigens and hydrazide derivatives
Shaik, Ahmad Ali,Nishat, Sharmeen,Andreana, Peter R.
, p. 2582 - 2585 (2015/06/16)
A selective glycosylation strategy enabling access to all stereochemical combinations of tumor associated Thomsen-nouveau (Tn) antigen, d-GalNAc-O-Ser/Thr, has been developed. The key component for selectivity is the phthalimide-protected d- or l-amino acid acceptors which allow access to α- or β-anomers in excellent yields (72-96%) and selectivity (～100%) when appropriate C-2 substitution is installed. The glycoamino acid intermediates were divergently converted to Tn-based carboxylates or to hydrazides by tandem Pd-C debenzylation followed by treatment with hydrazine hydrate or hydrazine hydrate treatment alone.
